Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanPan-C: Medical Cannabis for Symptom Burden in Advanced Pancreatic and Colorectal Cancer
NCT06605430Phase 2Recruiting
- Sponsor
- HealthPartners Institute
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in pancreatic cancer (PC), colorectal cancer (CRC), sponsored by HealthPartners Institute. Started Sep 2024; status: recruiting.
02
Drugs
cannabis
03
Conditions
pancreatic cancer (PC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06605430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605430.